[Federal Register: October 24, 2008 (Volume 73, Number 207)]
[Notices]
[Page 63523-63527]
[DOCID:fr24oc08-130]

-----------------------------------------------------------------------

SECURITIES AND EXCHANGE COMMISSION

[Investment Company Act Release No. 28441, 812-13497]

The Zweig Total Return Fund, Inc., et al.; Notice of Application

October 20, 2008.
AGENCY: Securities and Exchange Commission (``Commission'').

ACTION: Notice of application under section 6(c) of the Investment
Company Act of 1940 (``Act'') for an exemption from section 19(b) of
the Act and rule 19b-1 under the Act.

-----------------------------------------------------------------------

SUMMARY OF APPLICATION: Applicants request an Order to permit certain
closed-end investment companies to make periodic distributions of long-
term capital gains with respect to their outstanding common stock as
frequently as twelve times each year, and as frequently as
distributions are specified by or in accordance with the terms of any
outstanding preferred stock that such investment company may issue.

Applicants:  The Zweig Total Return Fund, Inc. (``ZTR''), The Zweig
Fund, Inc. (``ZF'') and Phoenix/Zweig Advisers LLC (the ``Adviser'').

Filing Dates:  February 14, 2008 and July 30, 2008.

Hearing or Notification of Hearing:  An Order granting the application
will be issued unless the Commission orders a hearing. Interested
persons may request a hearing by writing to the Commission's Secretary
and serving applicants with a copy of the request, personally or by
mail. Hearing requests should be received by the Commission by 5:30
p.m. on November 14, 2008, and should be accompanied by proof of
service on applicants, in the form of an affidavit or, for lawyers, a
certificate of service. Hearing requests should state the nature of the
writer's interest, the reason for the request, and the issues
contested. Persons who wish to be notified of a hearing may request
notification by writing to the Commission's Secretary.

ADDRESSES: Secretary, Securities and Exchange Commission, 100 F Street,
NE., Washington, DC 20549-1090. Applicants, c/o George R. Aylward,
President, Phoenix/Zweig Advisors LLC, 900 Third Avenue, New York, NY
10022.

FOR FURTHER INFORMATION CONTACT: Wendy Friedlander, Senior Counsel, at
(202) 551-6837, or James M. Curtis, Branch Chief, at<PHONE_NUMBER>
(Division of Investment Management, Office of Chief Counsel).

SUPPLEMENTARY INFORMATION: The following is a summary of the
application. The complete application may be obtained for a fee at the
Commission's Public Reference Room, 100 F Street, NE., Washington, DC
20549-1520 (telephone:<PHONE_NUMBER>).

Applicants' Representations

    1. Each of ZTR and ZF is a diversified closed-end management
investment company registered under the Act and

organized as a Maryland corporation.\1\ The common stock issued by ZTR
and ZF are listed on the New York Stock Exchange. The investment
objective of ZTR is total return consisting of capital appreciation and
current income. The investment objective of ZF is capital appreciation
primarily through investment in equity securities.
---------------------------------------------------------------------------

    \1\ Applicants request that any Order issued granting the relief
requested in the application also apply to any closed-end investment
company that in the future: (a) Is advised by the Adviser (including
any successor in interest) or any entity controlling, controlled by,
or under common control (within the meaning of section 2(a)(9) of
the Act) with the Adviser; and (b) complies with the terms and
conditions of the requested Order. A successor in interest is
limited to entities that result from a reorganization into another
jurisdiction or a change in the type of business organization.
---------------------------------------------------------------------------

    2. The Adviser is a Delaware corporation and is registered as an
investment adviser under the Investment Advisers Act of 1940. The
Adviser currently has no investment advisory clients other than ZTR and
ZF.
    3. Applicants represent that ZTR and ZF have each adopted fixed
distribution plans to make periodic, level distributions equal to 10%
per annum of their common stock's net asset value (``NAV''). ZTR
currently makes quarterly distributions and ZF currently makes monthly
distributions on their respective common stock. Applicants represent
that currently the capital gains distributions are funded by capital
loss carryovers available to each of ZTR and ZF but state that such
carryovers may not be available in the future.
    4. Applicants represent that on December 12, 2007, the Boards of
Directors of ZTR and ZF (each, a ``Board''), including a majority of
the directors who are not ``interested persons,'' as defined in section
2(a)(19) of the Act (the ``Independent Directors''), of ZTR and ZF each
approved and adopted their respective distribution policy and plan
(``Plan''). Applicants represent that the purpose of each Plan is to
continue to make regular distributions that are not dependent on the
timing or amount of investment income earned or capital gains realized
by ZTR or ZF. Applicants further represent that the Board of ZTR and ZF
each:
    (a) Determined that it is in the best interests of the respective
fund and its stockholders to adopt the Plan;
    (b) Requested and evaluated, and the Adviser furnished, such
information as may be reasonably necessary to make an informed
determination of whether each Plan should be adopted and implemented;
    (c) Determined that adoption and implementation of the Plan are
consistent with the respective fund's investment objective(s) and
policies and in the best interests of the respective fund and its
stockholders, after considering information provided pursuant to
representation 4(b) above, including, without limitation, with respect
to each Plan: (i) The purpose(s) of the Plan as stated in this
application; (ii) any potential or actual conflict of interest that the
Adviser, any affiliated person of the Adviser, or any other affiliated
person of the respective fund may have relating to the adoption or
implementation of the Plan; (iii) whether the rate of distribution
under the Plan will exceed the respective fund's expected total return
(in relation to the NAV); and (iv) any reasonably foreseeable material
effect of the Plan on the respective fund's long-term total return (in
relation to market price and the NAV of its common stock); and
    (d) Approved the respective fund's adoption of compliance policies
and procedures in accordance with rule 38a-1 under the Act to be
effective upon the issuance of the requested Order (``Compliance
Policies and Procedures'') that:
    (i) Are reasonably designed to ensure that all notices required to
be sent to the respective fund's common stockholders pursuant to
section 19(a) of the Act, rule 19a-1 thereunder and condition IV below
(each, a ``Notice'') include the disclosure required by rule 19a-1 and
by condition II.A below, and that all other communications by the fund
or its agents, described in condition III.A below, about the
distributions under its Plan include the disclosure required by
condition III.A below; and
    (ii) Require the respective fund to keep records that demonstrate
its compliance with all of the conditions of the Order and that are
necessary for the fund to form the basis for, or demonstrate the
calculation of, the amounts disclosed in its Notices.
    5. Applicants represent that at the December 12, 2007 meeting, the
Boards of each of ZTR and ZF, including a majority of its Independent
Directors, also adopted policies and procedures under rule 38a-1 under
the Act that are reasonably designed to ensure that all Notices comply
with Condition II below, and that all other written communications by
the funds or their agents regarding distributions under the Plans
include the disclosure required by Condition III below. Applicants
state that the Boards of ZTR and ZF also adopted policies and
procedures at that meeting that require the respective fund to keep
records that demonstrate each respective fund's compliance with all of
the conditions of the requested Order and that are necessary for each
respective fund to form the basis for, or demonstrate the calculation
of, the amounts disclosed in its Notices.
    6. Applicants represent that the Boards of ZTR and ZF have recorded
the basis for their approval of the Plans, including their
consideration of the factors listed in representation 4(c) above, in
its meeting minutes, which will be made and preserved for a period of
not less than six years from the date of such meeting, the first two
years in an easily accessible place, or such longer period as may
otherwise be required by law.

Applicants' Legal Analysis

    1. Section 19(b) provides that registered investment companies may
not, in contravention of such rules, regulations, or orders as the
Commission may prescribe, distribute long-term capital gains more often
than once every twelve months. Rule 19b-1 permits a registered
investment company with respect to any one taxable year, to make one
capital gain dividend, as defined in section 852(b)(3)(C) of the
Internal Revenue Code of 1986 (the ``Code''), plus a supplemental
distribution made pursuant to section 855 of the Code not exceeding 10%
of the total amount distributed for the year, plus one additional long-
term capital gains distribution to avoid the excise tax under section
4982 of the Code.
    2. Section 6(c) provides that the Commission may, by order upon
application, conditionally or unconditionally exempt any person,
security, or transaction, or any class or classes of persons,
securities or transactions, from any provision of the Act, if and to
the extent that the exemption is necessary or appropriate in the public
interest and consistent with the protection of investors and the
purposes fairly intended by the policy and provisions of the Act.
    3. Applicants assert that section 19(b) and rule 19b-1 may prevent
the operation of a Plan and effectively force fixed regular periodic
distributions to be funded with returns of capital (to the extent net
investment income and realized short-term capital gains are
insufficient), even though net realized long-term capital gains
otherwise would be available. Applicants state that the long-term
capital gains in excess of the fixed regular periodic distributions
permitted by the rule then must either be (1) added as an ``extra'' on
one of the permitted capital gains distributions, thus exceeding the
total annual amount called for by the Plan, or (2) retained by the
affected fund, with such fund

paying taxes on the amount retained. Applicants believe that their
stockholders should benefit from the continued investment of assets
that might otherwise be distributed as a return of capital in order to
fund the regular periodic distributions under the Plan.
    4. Applicants believe that the stockholders in each of the funds
include income-sensitive investors who desire steady distributions.
Applicants believe that funds with Plans may attract new investors and
support the market price of the fund's common stock. In addition,
Applicants believe that, without a Plan, there may be an increase in
the amount of any discount from NAV at which a fund's common stock may
trade.
    5. Applicants state that one of the concerns leading to the
enactment of section 19(b) and adoption of rule 19b-1 was that
stockholders might be unable to distinguish between frequent
distributions of capital gain and dividends from investment income.
Applicants state that, pursuant to its respective Plan, each fund will
provide stockholders with adequate disclosure to clearly inform
stockholders of the nature of each distribution they receive.
    6. Applicants assert that one of the goals of rule 19b-1 was to
reduce the possible inappropriate pressure on portfolio managers to
realize capital gains on a frequent basis and/or at times when
investment objective considerations would militate against doing so.
However, when applied to Plans like those of the ZTR and ZF, applicants
assert that rule 19b-1 actually may create an inappropriate influence
on portfolio management decisions by imposing pressure to limit the
realization of long-term capital gains to an annual total that is a
fraction of a fund's net investment income. Applicants assert that rule
19b-1 also may create pressure to ensure that realized capital gains
are short-term rather than long-term because the distribution of short-
term capital gains is not subject to the limitations of the rule.
Applicants seek an Order to minimize these anomalous effects by
enabling the funds to realize long-term capital gains as investment
considerations warrant and without fear of violating rule 19b-1.
    7. Applicants assert that another concern that led to the enactment
of section 19(b) of the Act and the adoption of rule 19b-1 was that
frequent capital gain distributions could facilitate improper fund
sales practices, including, in particular, the practice of urging an
investor to purchase shares of a fund on the basis of an upcoming
capital gains dividend (``selling the dividend''), where the dividend
results in an immediate corresponding reduction in net asset value and
is in effect a taxable return of the investor's capital. Applicants
submit that this concern does not apply to closed-end investment
companies, such as ZTR and ZF, which do not continuously distribute
shares.
    Applicants state that, in order to counteract any potential
``selling of the dividend'' issue in connection with a public offering
of the funds' common stock, any such public offering will be made in
accordance with Condition VI below. Applicants state that, in the case
of a rights offering, the offering will be made in accordance with
Condition VI.A below. Applicants argue that, under those circumstances,
the abuse of selling the dividend would not occur.
    8. Applicants argue that there is no public policy reason why
investors, with full disclosure of the nature of distributions,
including disclosure that such distributions may be, or include,
returns of capital, should not have the opportunity to invest in a
closed-end fund with a Plan independent of the fund's net investment
income and net capital gain, with the fund returning capital only to
the extent that net investment income and net capital gain for the year
plus previously undistributed related earnings and profit from prior
years are insufficient to meet the annual fixed distribution
requirement.

Applicants' Conditions

    Applicants agree that, with respect to each fund seeking to rely on
the Order, the Order will be subject to the following conditions:

I. Compliance Review and Reporting

    The fund's chief compliance officer will: (a) Report to the fund
Board, no less frequently than once every three months or at the next
regularly scheduled quarterly board meeting, whether (i) the fund and
the fund adviser have complied with the conditions to the requested
Order and (ii) a Material Compliance Matter, as defined in rule 38a-
1(e)(2), has occurred with respect to compliance with such conditions;
and (b) review the adequacy of the policies and procedures adopted by
the fund no less frequently than annually.

II. Disclosures to Fund Stockholders

    A. Each Notice to the holders of the fund's common stock, in
addition to the information required by section 19(a) and rule 19a-1:
    1. Will provide, in a tabular or graphical format:
    (a) The amount of the distribution, on a per common share basis,
together with the amounts of such distribution amount, on a per common
share basis and as a percentage of such distribution amount, from
estimated: (A) Net investment income; (B) net realized short-term
capital gains; (C) net realized long-term capital gains; and (D) return
of capital or other capital source;
    (b) The fiscal year-to-date cumulative amount of distributions, on
a per common share basis, together with the amounts of such cumulative
amount, on a per common share basis and as a percentage of such
cumulative amount of distributions, from estimated: (A) Net investment
income; (B) net realized short-term capital gains; (C) net realized
long-term capital gains; and (D) return of capital or other capital
source;
    (c) The average annual total return in relation to the change in
NAV for the 5-year period (or, if the fund's history of operations is
less than five years, the time period commencing immediately following
the fund's first public offering) ending on the last day of the month
prior to the most recent distribution declaration date compared to the
current fiscal period's annualized distribution rate expressed as a
percentage of NAV as of the last day of the month prior to the most
recent distribution declaration date; and
    (d) The cumulative total return in relation to the change in NAV
from the last completed fiscal year to the last day of the month prior
to the most recent distribution declaration date compared to the fiscal
year-to-date cumulative distribution rate expressed as a percentage of
NAV as of the last day of the month prior to the most recent
distribution declaration date.
    Such disclosure shall be made in a type size at least as large and
as prominent as the estimate of the sources of the current
distribution; and
    2. Will include the following disclosure:
    (a) ``You should not draw any conclusions about the fund's
investment performance from the amount of this distribution or from the
terms of the fund's Plan;''
    (b) ``The fund estimates that it has distributed more than its
income and net realized capital gains; therefore, a portion of your
distribution may be a return of capital. A return of capital may occur,
for example, when some or all of the money that you invested in the
fund is paid back to you. A return of capital distribution does not
necessarily reflect the fund's investment performance and

should not be confused with `yield' or `income';'' \2\ and
---------------------------------------------------------------------------

    \2\ The disclosure in this Condition II.A.2(b) will be included
only if the current distribution or the fiscal year-to-date
cumulative distributions are estimated to include a return of
capital.
---------------------------------------------------------------------------

    (c)''The amounts and sources of distributions reported in this
Notice are only estimates and are not being provided for tax reporting
purposes. The actual amounts and sources of the amounts for [accounting
and] tax reporting purposes will depend upon the fund's investment
experience during the remainder of its fiscal year and may be subject
to changes based on tax regulations. The fund will send you a Form
1099-DIV for the calendar year that will tell you how to report these
distributions for federal income tax purposes.''
    Such disclosure shall be made in a type size at least as large as
and as prominent as any other information in the Notice and placed on
the same page in close proximity to the amount and the sources of the
distribution.
    B. On the inside front cover of each report to stockholders under
rule 30e-1 under the Act, the fund will:
    1. Describe the terms of the Plan (including the fixed amount or
fixed percentage of the distributions and the frequency of the
distributions);
    2. Include the disclosure required by Condition II.A.2(a) above;
    3. State, if applicable, that the Plan provides that the Board may
amend or terminate the Plan at any time without prior notice to fund
stockholders; and
    4. Describe any reasonably foreseeable circumstances that might
cause the fund to terminate the Plan and any reasonably foreseeable
consequences of such termination.
    C. Each report provided to stockholders under rule 30e-1 and each
prospectus filed with the Commission on Form N-2 under the Act, will
provide the fund's total return in relation to changes in NAV in the
financial highlights table and in any discussion about the fund's total
return.

III. Disclosure to Stockholders, Prospective Stockholders and Third
Parties

    A. The fund will include the information contained in the relevant
Notice, including the disclosure required by Condition II.A.2 above, in
any written communication (other than a Form 1099) about the Plan or
distributions under the Plan by the fund, or agents that the fund has
authorized to make such communication on the fund's behalf, to any fund
common stockholder, prospective common stockholder, or third-party
information provider;
    B. The fund will issue, contemporaneously with the issuance of any
Notice, a press release containing the information in the Notice and
will file with the Commission the information contained in such Notice,
including the disclosure required by Condition II.A.2 above, as an
exhibit to its next filed Form N-CSR; and
    C. The fund will post prominently a statement on its (or the fund
adviser's) Web site containing the information in each Notice,
including the disclosure required by Condition II.A.2 above, and will
maintain such information on such Web site for at least 24 months.

IV. Delivery of 19(a) Notices to Beneficial Owners

    If a broker, dealer, bank, or other person (``financial
intermediary'') holds common stock issued by the fund in nominee name,
or otherwise, on behalf of a beneficial owner, the fund: (a) Will
request that the financial intermediary, or its agent, forward the
Notice to all beneficial owners of the fund's shares held through such
financial intermediary; (b) will provide, in a timely manner, to the
financial intermediary, or its agent, enough copies of the Notice
assembled in the form and at the place that the financial intermediary,
or its agent, reasonably requests to facilitate the financial
intermediary's sending of the Notice to each beneficial owner of the
fund's stock; and (c) upon the request of any financial intermediary,
or its agent, that receives copies of the Notice, will pay the
financial intermediary, or its agent, the reasonable expenses of
sending the Notice to such beneficial owners.

V. Additional Board Determinations for Funds Whose Common Stock Trades
at a Premium

    If:
    A. The fund's common stock has traded on the exchange that it
primarily trade on at the time in question at an average premium to NAV
equal to or greater than 10%, as determined on the basis of the average
of the discount or premium to NAV of the fund's common stock as of the
close of each trading day over a 12-week rolling period (each such 12-
week rolling period ending on the last trading day of each week); and
    B. The fund's annualized distribution rate for such 12-week rolling
period, expressed as a percentage of NAV as of the ending date of such
12-week rolling period, is greater than the fund's average annual total
return in relation to the change in NAV over the 2-year period ending
on the last day of such 12-week rolling period; then:
    1. At the earlier of the next regularly scheduled meeting or within
four months of the last day of such 12-week rolling period, the Board,
including a majority of the Independent Directors:
    (a) Will request and evaluate, and the fund's adviser will furnish,
such information as may be reasonably necessary to make an informed
determination of whether the Plan should be continued or continued
after amendment;
    (b) Will determine whether continuation, or continuation after
amendment, of the Plan is consistent with the fund's investment
objective(s) and policies and in the best interests of the fund and its
shareholders, after considering the information in Condition V.B.1(a)
above, including, without limitation:
    (1) Whether the Plan is accomplishing its purpose(s);
    (2) The reasonably foreseeable material effects of the Plan on the
fund's long-term total return in relation to the market price and NAV
of the fund's common stock; and
    (3) The fund's current distribution rate, as described in Condition
V.B above, compared to the fund's average annual total return over the
2-year period, as described in Condition V.B, or such longer period as
the board deems appropriate; and
    (c) Based upon that determination, will approve or disapprove the
continuation, or continuation after amendment, of the Plan.
    (2) The Board will record the information considered by it and the
basis for its approval or disapproval of the continuation, or
continuation after amendment, of the Plan in its meeting minutes, which
must be made and preserved for a period of not less than six years from
the date of such meeting, the first two years in an easily accessible
place.

VI. Public Offerings

    The fund will not make a public offering of the fund's common stock
other than:
    A. A rights offering below net asset value to holders of the fund's
common stock;
    B. An offering in connection with a dividend reinvestment plan,
merger, consolidation, acquisition, spin-off or reorganization of the
fund; or
    C. An offering other than an offering described in Conditions VI.A
and VI.B above, unless, with respect to such other offering:
    1. The fund's average annual distribution rate for the six months

ending on the last day of the month ended immediately prior to the most
recent distribution declaration date,\3\ expressed as a percentage of
NAV per share as of such date, is no more than 1 percentage point
greater than the fund's average annual total return for the 5-year
period ending on such date; \4\ and
---------------------------------------------------------------------------

    \3\ If the fund has been in operation fewer than two years, the
measured period will begin immediately following the fund's first
public offering.
    \4\ If the fund has been in operation fewer than five years, the
measured period will begin immediately following the fund's first
public offering.
---------------------------------------------------------------------------

    2. The transmittal letter accompanying any registration statement
filed with the Commission in connection with such offering discloses
that the fund has received an Order under section 19(b) to permit it to
make periodic distributions of long-term capital gains with respect to
its common stock as frequently as twelve times each year, and as
frequently as distributions are specified in accordance with the terms
of any outstanding preferred stock that such fund may issue.

VII. Amendments to Rule 19b-1

    The requested relief will expire on the effective date of any
amendment to rule 19b-1 that provides relief permitting certain closed-
end investment companies to make periodic distributions of long-term
capital gains with respect to their outstanding common shares as
frequently as twelve times each year.

    For the Commission, by the Division of Investment Management,
under delegated authority.
Florence E. Harmon,
Acting Secretary.
 [FR Doc. E8-25361 Filed 10-23-08; 8:45 am]

BILLING CODE 8011-01-P


[Federal Register Volume 77, Number 25 (Tuesday, February 7, 2012)]
[Notices]
[Page 6109]
[FR Doc No: 2012-2718]

-----------------------------------------------------------------------

DEPARTMENT OF ENERGY

Federal Energy Regulatory Commission

[Docket No. ER12-896-000]

Mariposa Energy, LLC; Supplemental Notice That Initial Market-
Based Rate Filing Includes Request for Blanket Section 204
Authorization

    This is a supplemental notice in the above-referenced proceeding of
Mariposa Energy, LLC's application for market-based rate authority,
with an accompanying rate tariff, noting that such application includes
a request for blanket authorization, under 18 CFR part 34, of future
issuances of securities and assumptions of liability.
    Any person desiring to intervene or to protest should file with the
Federal Energy Regulatory Commission, 888 First Street NE., Washington,
DC 20426, in accordance with Rules 211 and 214 of the Commission's
Rules of Practice and Procedure (18 CFR 385.211 and 385.214). Anyone
filing a motion to intervene or protest must serve a copy of that
document on the Applicant.
    Notice is hereby given that the deadline for filing protests with
regard to the applicant's request for blanket authorization, under 18
CFR part 34, of future issuances of securities and assumptions of
liability, is February 21, 2012.
    The Commission encourages electronic submission of protests and
interventions in lieu of paper, using the FERC Online links at http://www.ferc.gov. To facilitate electronic service, persons with Internet
access who will eFile a document and/or be listed as a contact for an
intervenor must create and validate an eRegistration account using the
eRegistration link. Select the eFiling link to log on and submit the
intervention or protests.
    Persons unable to file electronically should submit an original and
14 copies of the intervention or protest to the Federal Energy
Regulatory Commission, 888 First Street NE., Washington, DC 20426.
    The filings in the above-referenced proceeding are accessible in
the Commission's eLibrary system by clicking on the appropriate link in
the above list. They are also available for review in the Commission's
Public Reference Room in Washington, DC. There is an eSubscription link
on the Web site that enables subscribers to receive email notification
when a document is added to a subscribed docket(s). For assistance with
any FERC Online service, please email<EMAIL_ADDRESS>or
call<PHONE_NUMBER> (toll free). For TTY, call<PHONE_NUMBER>.

    Dated: January 31, 2012.
Nathaniel J. Davis, Sr.,
Deputy Secretary.
[FR Doc. 2012-2718 Filed 2-6-12; 8:45 am]
BILLING CODE 6717-01-P


[Federal Register: March 15, 2007 (Volume 72, Number 50)]
[Notices]
[Page 12169-12170]
[DOCID:fr15mr07-52]

-----------------------------------------------------------------------

DEPARTMENT OF ENERGY

Federal Energy Regulatory Commission

[Docket No. RP07-340-000]

Columbia Gas Transmission Corporation; Notice of Proposed Changes
in FERC Gas Tariff

March 9, 2007.
    Take notice that on March 6, 2007, Columbia Gas Transmission
Corporation (Columbia) tendered for filing as part of its FERC Gas
Tariff, Second Revised Volume No. 1, the following revised tariff
sheets with a proposed effective date of June 1, 2007:

Fifth Revised Sheet No. 390
Original Sheet No. 390A
Sixth Revised Sheet No. 391
Second Revised Sheet No. 392

    Any person desiring to intervene or to protest this filing must
file in accordance with Rules 211 and 214 of the Commission's Rules of
Practice and Procedure (18 CFR 385.211 and 385.214). Protests will be
considered by the Commission in determining the appropriate action to
be taken, but will not serve to make protestants parties to the
proceeding. Any person wishing to become a party must file a notice of
intervention or motion to intervene, as

appropriate. Such notices, motions, or protests must be filed in
accordance with the provisions of Section 154.210 of the Commission's
regulations (18 CFR 154.210). Anyone filing an intervention or protest
must serve a copy of that document on the Applicant. Anyone filing an
intervention or protest on or before the intervention or protest date
need not serve motions to intervene or protests on persons other than
the Applicant.
    The Commission encourages electronic submission of protests and
interventions in lieu of paper using the ``eFiling'' link at http://www.ferc.gov.
 Persons unable to file electronically should submit an

original and 14 copies of the protest or intervention to the Federal
Energy Regulatory Commission, 888 First Street, NE., Washington, DC
20426.
    This filing is accessible on-line at http://www.ferc.gov, using the

``eLibrary'' link and is available for review in the Commission's
Public Reference Room in Washington, DC. There is an ``eSubscription''
link on the Web site that enables subscribers to receive e-mail
notification when a document is added to a subscribed docket(s). For
assistance with any FERC Online service, please e-mail
<EMAIL_ADDRESS>or call<PHONE_NUMBER> (toll free). For

TTY, call<PHONE_NUMBER>.

Philis J. Posey,
Acting Secretary.
[FR Doc. E7-4719 Filed 3-14-07; 8:45 am]

BILLING CODE 6717-01-P


Comment Info: =================

General Comment:SUPPLEMENTAL MATERIALS:

Notice of meeting of negotiated rulemaking committee on oil spill response plans and finalization of committee membership

PAGES:  1


[Federal Register Volume 79, Number 5 (Wednesday, January 8, 2014)]
[Notices]
[Pages 1384-1385]
[FR Doc No: 2014-00088]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. FDA-2014-N-0001]

Joint Meeting of the Arthritis Advisory Committee and the Drug
Safety and Risk Management Advisory Committee; Notice of Meeting

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

    This notice announces a forthcoming meeting of public advisory
committees of the Food and Drug Administration

(FDA). The meeting will be open to the public.
    Name of Committees: Arthritis Advisory Committee and the Drug
Safety and Risk Management Advisory Committee.
    General Function of the Committees: To provide advice and
recommendations to the Agency on FDA's regulatory issues.
    Date and Time: The meeting will be held on February 10 and 11,
2014, from 8 a.m. to 5 p.m.
    Location: FDA White Oak Campus, 10903 New Hampshire Ave., Bldg. 31
Conference Center, the Great Room (Rm. 1503), Silver Spring, MD 20993-
0002. Information regarding special accommodations due to a disability,
visitor parking, and transportation may be accessed at: http://www.fda.gov/AdvisoryCommittees/default.htm; under the heading
``Resources for You,'' click on ``Public Meetings at the FDA White Oak
Campus.'' Please note that visitors to the White Oak Campus must enter
through Building 1.
    Contact Person: Stephanie L. Begansky, Center for Drug Evaluation
and Research, Food and Drug Administration, 10903 New Hampshire Ave.,
Bldg. 31, Rm. 2417, Silver Spring, MD 20993-0002,<PHONE_NUMBER>, FAX:
301-847-8533, email<EMAIL_ADDRESS>or FDA Advisory Committee
Information Line, 1-800-741-8138<PHONE_NUMBER> in the Washington, DC
area). A notice in the Federal Register about last minute modifications
that impact a previously announced advisory committee meeting cannot
always be published quickly enough to provide timely notice. Therefore,
you should always check the Agency's Web site at http://www.fda.gov/AdvisoryCommittees/default.htm and scroll down to the appropriate
advisory committee meeting link, or call the advisory committee
information line to learn about possible modifications before coming to
the meeting.
    Agenda: The committees will discuss data and analyses published in
2006 or later that are relevant to further understanding the
relationship between nonsteroidal anti-inflammatory drugs (NSAIDs) and
cardiovascular thrombotic risk that is currently described in NSAID
class labeling.
    FDA intends to make background material available to the public no
later than 2 business days before the meeting. If FDA is unable to post
the background material on its Web site prior to the meeting, the
background material will be made publicly available at the location of
the advisory committee meeting, and the background material will be
posted on FDA's Web site after the meeting. Background material is
available at http://www.fda.gov/AdvisoryCommittees/Calendar/default.htm. Scroll down to the appropriate advisory committee meeting
link.
    Procedure: Interested persons may present data, information, or
views, orally or in writing, on issues pending before the committee.
Written submissions may be made to the contact person on or before
January 27, 2014. Oral presentations from the public will be scheduled
on February 11, 2014, between approximately 9 a.m. and 11 a.m. Those
individuals interested in making formal oral presentations should
notify the contact person and submit a brief statement of the general
nature of the evidence or arguments they wish to present, the names and
addresses of proposed participants, and an indication of the
approximate time requested to make their presentation on or before
January 16, 2014. Time allotted for each presentation may be limited.
If the number of registrants requesting to speak is greater than can be
reasonably accommodated during the scheduled open public hearing
session, FDA may conduct a lottery to determine the speakers for the
scheduled open public hearing session. The contact person will notify
interested persons regarding their request to speak by January 17,
2014.
    Persons attending FDA's advisory committee meetings are advised
that the Agency is not responsible for providing access to electrical
outlets.
    FDA welcomes the attendance of the public at its advisory committee
meetings and will make every effort to accommodate persons with
physical disabilities or special needs. If you require special
accommodations due to a disability, please contact Stephanie L.
Begansky at least 7 days in advance of the meeting.
    FDA is committed to the orderly conduct of its advisory committee
meetings. Please visit our Web site at http://www.fda.gov/AdvisoryCommittees/AboutAdvisoryCommittees/ucm111462.htm for procedures
on public conduct during advisory committee meetings.
    Notice of this meeting is given under the Federal Advisory
Committee Act (5 U.S.C. app. 2).

    Dated: January 3, 2014.
Jill Hartzler Warner,
Acting Associate Commissioner for Special Medical Programs.
[FR Doc. 2014-00088 Filed 1-7-14; 8:45 am]
BILLING CODE 4160-01-P